Site icon OncologyTube

Marina Konopleva, MD, Ph.D – Venetoclax Resistance – MD-Education

Marina Konopleva, M.D., Ph.D. Professor, Department of Oncology (Medical Oncology) and Department of Molecular Pharmacology Albert Einstein College of Medicine Jack and Pearl Resnick Campus

Marina Konopleva, MD, PhD, is a distinguished name in the realm of medical research, serving as the Director of Leukemia at the renowned Einstein Medical Center in New York. With an esteemed cross-appointment at both Ambient’s and Casanthe, Licky Merplatte, Marina Konopleva stands as a prominent authority in the study of leukemia and its intricate treatment mechanisms.

REGISTER NOW TO JOIN US AT THESE UPCOMING EVENTS
AML-ALL US – Online content available – https://aml-allus2023.md-education.com/register/
AML-ALL EU – Registration open – https://aml-alleu2023.md-education.com/register/
MPN-MDS EU – registration open – https://mpn-mdseu2023.md-education.com/register/
Register – AML-ALL US Focus Meeting 2023
aml-allus2023.md-education.com

A pivotal focus of Marina Konopleva’s expertise revolves around unraveling the complex mechanisms of resistance, particularly centered on optimizing the inhibition of venetoclax—a cornerstone of targeted therapy.

Exit mobile version